Chinese Journal of Pharmacovigilance ›› 2024, Vol. 21 ›› Issue (12): 1382-1387.
DOI: 10.19803/j.1672-8629.20240654

Previous Articles     Next Articles

Advancements in Treating Ischemic Stroke with Chinese Medicine Compounds Formulae

LIU Wenjie1,2, GAO Yuanyuan2, BAI Xue1,*   

  1. 1Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment of Major Disease, Beijing 100700, China;
    2The First Clinical Medical College, Henan University of ChineseMedicine, Zhengzhou Henan 450046, China
  • Received:2024-08-23 Online:2024-12-15 Published:2024-12-16

Abstract: Objective To examine findings related to the applications of TCM compound formulae in the management of ischemic stroke, and to offer data for subsequent clinical and experimental investigations. Methods By searching China Knowledge Network and PubMed for articles published from the inception to October 20, 2024, TCM compound formulae were summarized and evaluated. Results Clinical investigations indicated that TCM compound formulae, including Buyang Huanwu Tang, Xinglou Chengqi Tang, and Taohong Siwu Tang, exhibited substantial therapeutic efficacy in patients with ischemic stroke. Conclusion TCM compound formulae possess considerable benefits in the management of ischemic stroke. However, investigations are comparatively limited, and there is a lack of clinical studies and large-scale trials. Multi-sample and high-quality clinical studies are lacking.

Key words: TCM Compound Formulae, Ischemic Stroke, Buyang Huanwu Tang, Xinglou Chengqi Tang, Taohong Siwu Decoction, Dengzhan Shengmai Capsules, Xue Fu Zhu Yu Tang

CLC Number: